{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:02:29Z","timestamp":1791295349999,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-008"],"award-info":[{"award-number":["2021-I2M-1-008"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011635","name":"Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e22222","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T16:38:40Z","timestamp":1699979920000},"page":"e22222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study)"],"prefix":"10.1016","volume":"9","author":[{"given":"Zheng","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gang","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Fei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.heliyon.2023.e22222_bib1","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1253\/circj.CJ-12-0468","article-title":"Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: new findings from optical coherence tomography and pathology","volume":"76","author":"Wang","year":"2012","journal-title":"Circ. J."},{"issue":"18","key":"10.1016\/j.heliyon.2023.e22222_bib2","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e22222_bib3","article-title":"Effects of a secondary prevention combination therapy with beta-blocker and statin on major adverse cardiovascular events in acute coronary syndrome patients","volume":"26","author":"Zhu","year":"2020","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22222_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12944-017-0544-0","article-title":"Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes","volume":"16","author":"Xie","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e22222_bib5","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/ATVBAHA.115.306037","article-title":"Effect of high-dose statin therapy on drug-eluting stent strut coverage","volume":"35","author":"Kim","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22222_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3349\/ymj.2015.56.1.45","article-title":"Impact of statin treatment on strut coverage after drug-eluting stent implantation","volume":"56","author":"Suh","year":"2015","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e22222_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.118.038840","article-title":"Effect of alirocumab on mortality after acute coronary syndromes","volume":"140","author":"Steg","year":"2019","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.heliyon.2023.e22222_bib8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e22222_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"22","key":"10.1016\/j.heliyon.2023.e22222_bib10","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e22222_bib11","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)","volume":"74","author":"Koskinas","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22222_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2012.08.037","article-title":"Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography","volume":"111","author":"Kim","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e22222_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.amjcard.2006.11.068","article-title":"Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation","volume":"99","author":"Takano","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e22222_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2008.05.069","article-title":"The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography","volume":"134","author":"Tanigawa","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22222_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCINTERVENTIONS.113.000797","article-title":"Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation","volume":"7","author":"Im","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e22222_bib16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.amjcard.2006.01.031","article-title":"Assessment of coronary arterial thrombus by optical coherence tomography","volume":"97","author":"Kume","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e22222_bib17","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.ijcard.2013.07.160","article-title":"Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up","volume":"168","author":"Kim","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e22222_bib18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jcmg.2012.01.024","article-title":"Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT","volume":"5","author":"Kim","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22222_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pcad.2020.02.009","article-title":"Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: learning from pathophysiology to optimize treatment","volume":"63","author":"Mangiacapra","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e22222_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e22222_bib21","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2005.02.086","article-title":"Late angiographic stent thrombosis (LAST) events with drug-eluting stents","volume":"45","author":"Ong","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e22222_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123838","article-title":"Endothelial function: a short guide for the interventional cardiologist","volume":"19","author":"Gori","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.heliyon.2023.e22222_bib23","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2018.02.023","article-title":"Restenosis, stent thrombosis, and bleeding complications: navigating between Scylla and charybdis","volume":"71","author":"Torrado","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e22222_bib24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/ehjci\/jeu042","article-title":"Serial optical frequency domain imaging in STEMI patients: the follow-up report of TROFI study","volume":"15","author":"Garc\u00eda-Garc\u00eda","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e22222_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcin.2013.12.205","article-title":"The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis","volume":"7","author":"Kim","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22222_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ. Res."},{"issue":"5302","key":"10.1016\/j.heliyon.2023.e22222_bib27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e22222_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/hrt.2008.146662","article-title":"Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis","volume":"95","author":"Thomas","year":"2009","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e22222_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2008.11.198","article-title":"Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics","volume":"142","author":"Lee","year":"2010","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e22222_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3892\/etm.2015.2571","article-title":"Association between mobilization of circulating endothelial progenitor cells and time or degree of injury from angioplasty in patients with exertional angina: a prospective study","volume":"10","author":"Gao","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e22222_bib31","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/hc2401.092816","article-title":"Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease","volume":"103","author":"Vasa","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22222_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016413","article-title":"Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries","volume":"6","author":"Hibbert","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e22222_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/clc.4960270405","article-title":"Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation","volume":"27","author":"Hognestad","year":"2004","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22222_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cardiores.2005.06.029","article-title":"Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform","volume":"68","author":"Jaschke","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22222_bib35","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1038\/s41598-021-88941-x","article-title":"Endogenous PCSK9 may influence circulating CD45(neg)\/CD34(bright) and CD45(neg)\/CD34(bright)\/CD146(neg) cells in patients with type 2 diabetes mellitus","volume":"11","author":"Tripaldi","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e22222_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10557-020-07119-1","article-title":"The effect of proprotein convertase subtilisin kexin type 9 inhibitors on circulating endothelial progenitor cells in patients with cardiovascular disease","volume":"36","author":"Itzhaki Ben Zadok","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e22222_bib37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.diabet.2017.07.009","article-title":"Circulating PCSK9 levels in acute coronary syndrome: results from the PC-SCA-9 prospective study","volume":"43","author":"Cariou","year":"2017","journal-title":"Diabetes Metab."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e22222_bib38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e22222_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/life11060466","article-title":"Antiplatelet effects of PCSK9 inhibitors in primary hypercholesterolemia","volume":"11","author":"P\u0119czek","year":"2021","journal-title":"Life"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e22222_bib40","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e22222_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s13167-017-0106-6","article-title":"PCSK9 signaling pathways and their potential importance in clinical practice","volume":"8","author":"Wici\u0144ski","year":"2017","journal-title":"EPMA J."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e22222_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064145","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)","volume":"8","author":"Canuel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e22222_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.thromres.2022.03.021","article-title":"Pleiotropic effects of PCSK9-inhibition on hemostasis: anti-PCSK9 reduce FVIII levels by enhancing LRP1 expression","volume":"213","author":"Paciullo","year":"2022","journal-title":"Thromb. Res."},{"issue":"23","key":"10.1016\/j.heliyon.2023.e22222_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312640","article-title":"PCSK9 induces tissue factor expression by activation of TLR4\/NFkB signaling","volume":"22","author":"Scalise","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22222_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4244\/EIJV12I3A51","article-title":"Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention","volume":"12","author":"De Servi","year":"2016","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e22222_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehq390","article-title":"Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation","volume":"32","author":"Gresele","year":"2011","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e22222_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/eurheartj\/ehp433","article-title":"Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis","volume":"31","author":"Prati","year":"2010","journal-title":"Eur. Heart J."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023094306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023094306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:40:44Z","timestamp":1791294044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023094306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2405844023094306"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22222","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study)","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e22222"}}